+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 99Years
All Genders
ID07783412

Evaluating Topical Ruxolitinib Cream for Healing Ulcers in Adults with Pyoderma Gangrenosum

Led by Oregon Health and Science University · Updated on 2026-10-09

12

Participants Needed

1

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

This research evaluates topical ruxolitinib cream as a treatment for adults with Pyoderma Gangrenosum PG, a rare, chronic inflammatory skin disease that causes painful ulcers. The study aims to determine if this topical medication helps heal ulcers completely without needing systemic immunosuppressive drugs. PG is commonly treated with systemic therapies that can have serious long-term side effects, so this trial explores a potentially safer topical option targeting the JAK-STAT pathway involved in the disease. Participants will apply ruxolitinib 1.5% cream twice daily to the ulcer for 24 weeks while continuing their usual wound care, which may include cleansing, dressings, compression, and debridement as needed. No new systemic immunosuppressive treatments will be introduced during the study. After 24 weeks of treatment, those who respond well and remain safe may join a 48-week extension phase to continue using the cream under observation. Throughout the 28-week study period, participants attend 10 visits including screening and follow-ups, some of which can be done via telemedicine if living far from the site. Assessments include skin exams, ultrasound imaging, blood tests for safety and infections, wound fluid analysis, and patient questionnaires on symptoms and quality of life. The main outcome measured is the complete healing of the target ulcer by Week 24, along with secondary measures like pain reduction, ulcer size change, and quality-of-life improvements. Safety and long-term effects will also be monitored.

CONDITIONS

Brief Title

Topical Ruxolitinib in the Treatment of Adults With Pyoderma Gangrenosum

Research Team

A

Alexandra Shinde, MSc

C

Chloe Vignola

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here